Development
Medtronic plc
MDT
$87.44
$0.440.51%
NYSE
| 01/26/2024 | 10/27/2023 | 07/28/2023 | 04/28/2023 | 01/27/2023 | |
|---|---|---|---|---|---|
| Net Income | 4.20B | 4.10B | 3.62B | 3.76B | 4.06B |
| Total Depreciation and Amortization | 2.65B | 2.68B | 2.68B | 2.68B | 2.71B |
| Total Amortization of Deferred Charges | 253.00M | 253.00M | 253.00M | 253.00M | -- |
| Total Other Non-Cash Items | 216.00M | 370.00M | 320.00M | 320.00M | 271.00M |
| Change in Net Operating Assets | -850.00M | -1.84B | -1.04B | -967.00M | -1.41B |
| Cash from Operations | 6.47B | 5.57B | 5.83B | 6.04B | 5.64B |
| Capital Expenditure | -1.54B | -1.53B | -1.39B | -1.46B | -1.47B |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -74.00M | -22.00M | -676.00M | -1.87B | -1.87B |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -532.00M | -178.00M | -384.00M | -167.00M | 590.00M |
| Cash from Investing | -2.15B | -1.73B | -2.45B | -3.49B | -2.75B |
| Total Debt Issued | 2.36B | 2.95B | 5.91B | 7.69B | 6.34B |
| Total Debt Repaid | -5.21B | -5.98B | -5.98B | -8.29B | -3.08B |
| Issuance of Common Stock | 305.00M | 304.00M | 342.00M | 308.00M | 294.00M |
| Repurchase of Common Stock | -607.00M | -546.00M | -461.00M | -645.00M | -1.95B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -3.66B | -3.65B | -3.63B | -3.62B | -3.55B |
| Other Financing Activities | -177.00M | -699.00M | -690.00M | -409.00M | -61.00M |
| Cash from Financing | -6.98B | -7.62B | -4.51B | -4.96B | -2.02B |
| Foreign Exchange rate Adjustments | -244.00M | 252.00M | 326.00M | 243.00M | 173.00M |
| Miscellaneous Cash Flow Adjustments | 1.00M | 1.00M | 0.00 | 0.00 | 0.00 |
| Net Change in Cash | -2.90B | -3.52B | -801.00M | -2.17B | 1.04B |